fda tirzepatide shortage update today says of GLP-1 drug is over FDA says the tirzepatide weight-loss

I remain excited about the future of integrative care in neurodevelopmental disorders and look forward to continued dialogue and research that could one day expand our therapeutic toolkit in ways we once thought improbable

Its good to see studies like this - when you have clear numbers, its easier to talk with patients without relying on just trust us. The risks are always there, but what matters is understanding their scale, not imagining the worst

This product has not been evaluated by the FDA or any equivalent regulatory authority

GLP-1 medications are doing more than just helping with weight loss or blood sugar control

PubMed Pickart, L., Vasquez-Soltero, J.M., Margolina, A

Stewart, T.E